Saturday, September 12, 2009

Thursday, September 10, 2009

Google Plans Tools to Help News Media Charge for Content - Bits Blog - NYTimes.com

Google Plans Tools to Help News Media Charge for Content - Bits Blog - NYTimes.com
Google is planning to roll out a system of micropayments within the next year (ED 2009 to 2010) and hopes that newspapers will use it as they look for new ways to charge users for their content.

Saturday, May 24, 2008

Pick of the week
Ticker: NYC:USU
Company: USEC
USU is a low risk play that might result in significant upside. It isnear its all time low. Its trading BELOW BOOK VALUE.Has a stock price increase of at least 30% in the past month, a marketcap of greater than $100 million, and a beta of less than 3.It is easing off today, reaching its week low on lazy Friday trading,showing slow accumulation, and higher than average volume this week.
Company Tangible Book Value Multiple 1-Year Change
USEC (NYSE: USU) 0.5(73.4%)
More info
http://www.thestockmasters.com/usu-050708.html
http://seekingalpha.com/article/72224-jefferies-goldman-bullish-on-usec-actionable-trading-call-alert

HOLD.
This stock's P/E ratio indicates a discount compared to anaverage of 18.34 for the Oil, Gas & Consumable Fuels industry and a significant discount compared to the S&P 500 average of 21.54. Foradditional comparison, its price-to-book ratio of 0.51 indicates asignificant discount versus the S&P 500 average of 2.65 and a significant discount versus the industry average of 6.06. The price-to-sales ratio is wellbelow both the S&P 500 average and the industry average, indicating adiscount. Upon assessment of these and other key valuation criteria, USEC INC proves to trade at a discount to investment alternatives within the industry.

Monday, October 01, 2007

The Camel Club – David Baldacci
2 - Barely readable
Good for a read on the plane. A bit stilted at times in prose, character development is poor, and the plot is not credible. However the author's basic message is admirable. This book reads more like a poor screen play, than an international bestseller.


Sunday, September 16, 2007

Ratings

1. Don't even bother
2. Barely readable; expect some pain
3. Average; acceptable fare for its genre
4. Very Good; worth a read
5. Cherish

Medalon
La Trilogie de l'Enfant Demon: 1
Jennifer Fallon, 2000
Libraire L'Atalante, 2007, pour la traduction francaise
ISBN 978-2-84172-361-4
KGB Rating: Average

Monday, October 10, 2005

Viagra saving endangered species

Viagra is now saving endangered species. If you don't believe then read for yourself:
Of course, the report in question was funded by Pfizer Inc., no surprise there. These articles are quite different to those that appeared quite some time ago, where it was predicted that Viagra would not stem the tide of endangered specie slaughter.
The eminent study was conducted by the University of South Wales and the University of Alaska, notably two brothers: Bill von Hippel, a psychologist from the University of New South Wales (Sydney, Australia), and his brother, Dr Frank von Hippel, a biologist from the University of Alaska, Anchorage.

The researcher's home page:
William Von Hippel, Ph.D?

A previous report: Is Viagra a viable conservation tool?

So whom among your favorite species are getting a break? Apparently seals, sea lions, seahorses, pipefishes, deer, and geckos. Unfortunately for you cat and kitten lovers, sea turtles and tigers are still endangered because they are among the most commonly used for pain relief remedies, especially among the elderly population suffering from arthritis and gout in the largest Traditional Medecine markets such as China, Hong Kong, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand. Nevertheless these countries are rapidly adopting Viagra in lieu of their traditional remedies (I guess because it works better). Unfortunately there is no super drug as yet for arthritis.

"Arthriga - the Arthralgia Killer!" This wonderful drug will save endangered species all over the world. You're invited to join the "Arthriga Movement", dedicated to the promotion of the research, development, and commercialisation of Arthriga.

Friday, August 31, 2001

The first blog is here!